Where innovative Medical Go-To-Market Success is the rule! 

Want to Learn or See More? Click here

Synergistic Marketing, founded in 1990 by Mark Lutvak, is a successful, growing and profitable sales and marketing contracting firm and consultancy. We are dedicated to serving Small Emerging businesses that own or possess Medical Technology or Medical Device IP. We support our clients with a go-to-market strategy that takes advantage of our extensive network of medical industry companies as well as our extensive list of contacts who are our Corporate Partners.

Want to Learn or See More? Click here


Medical Technology and Device News Title

  • February 8, 2017:

    Researchers at MIT and Brigham and Women’s Hospital have designed and demonstrated a small voltaic cell that is sustained by the acidic fluids in the stomach. The system can generate enough power to run small sensors or drug delivery devices that can reside in the gastrointestinal tract for extended periods of time. This type of power could offer a safer and lower-cost alternative to the traditional batteries now used to power such devices, the researchers say.Full Story

  • February 7, 2017:

    DARPA’s RadioBio announced a program to prove whether terahertz electromagnetic waves constitute purposeful signals for biological function and if evidence supports that it does, to determine what information is being transferred. Even as far back as the 1960’s researchers have suggested such signals, but lacked the technology and tools to conduct reproducible experiments.
    The validity of existing and new electromagnetic bio-signaling claims requires an understanding of how the structure and function of microscopic, natural antennas are capable of generating and receiving information in a noisy spectral environment.Full Story

  • January 27, 2017:

    Polyhedral boranes, or clusters of boron atoms bound to hydrogen atoms, are transforming the biomedical industry. Now, a researcher at the University of Missouri has discovered an entirely new class of materials based on boranes that might have widespread potential medical applications, including improved diagnostic tools for cancer and other diseases as well as low-cost solar energy cells.Full Story

  • January 25, 2017:

    Atrial fibrillation (AF) AF is the most common heart rhythm disturbance and incidence is rising with an estimated 14 to 17 million patients in Europe and growing rapidly. AF increases the risk of death by two-fold in women and 1.5-fold in men, it causes 20-30 percent of all strokes, and it reduces quality of life because of palpitations, shortness of breath, tiredness, weakness, and psychological distress.
    Catheter ablation treats Atrial Fibrillation by using a long wire threaded through the blood vessels into the heart and used to burn or freeze small areas of the atrium. This creates a scar and destroys or fences off abnormal electrical signals so patients become asymptomatic.Full Story

  • January 10, 2017:

    PKVitality showed off what we think is the best CES product so far - Dubbed “K’Track”, this wearable wristband has the looks of a common smartwatch, but the functionality of a glucometer. Underneath the watch face where you typically find a heart rate sensor is a special sensor unit called the “K’apsul” consisting of an array of tiny micro-needles. These microneedles painless penetrate the topmost layer of skin and analyzes the interstitial fluid. The medical version of the wearable, K’Track Glucose, monitors the user’s glucose levels, while the fitness version, K’Track Athlete, measures the amount of lactic acid in the interstitial fluid.Full Story